ATE521619T1 - Neue erythromycin-derivate, verfahren zu deren herstellung sowie deren verwendung als arzneimittel - Google Patents

Neue erythromycin-derivate, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Info

Publication number: ATE521619T1
Authority: AT; Austria
Prior art keywords: erythromycin derivatives; production; medicinal products; new; new erythromycin
Prior art date: 1998-07-09

Application number

AT99401706T

Other languages

English (en)

Inventor

Alexis Denis

Giuseppe Gigliotti

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-09

Filing date

1999-07-08

Publication date

2011-09-15

1998-07-09 Priority claimed from FR9808795A external-priority patent/FR2780977B1/fr

1999-04-26 Priority claimed from FR9905245A external-priority patent/FR2792637B1/fr

1999-07-08 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2011-09-15 Application granted granted Critical

2011-09-15 Publication of ATE521619T1 publication Critical patent/ATE521619T1/de

Links

ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title abstract 3
229940126601 medicinal product Drugs 0.000 title 1
125000002252 acyl group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

AT99401706T 1998-07-09 1999-07-08 Neue erythromycin-derivate, verfahren zu deren herstellung sowie deren verwendung als arzneimittel ATE521619T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9808795A FR2780977B1 (fr)	1998-07-09	1998-07-09	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR9905245A FR2792637B1 (fr)	1999-04-26	1999-04-26	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number	Publication Date
ATE521619T1 true ATE521619T1 (de)	2011-09-15

Family

ID=26234434

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99401706T ATE521619T1 (de)	1998-07-09	1999-07-08	Neue erythromycin-derivate, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Country Status (8)

Country	Link
US (1)	US6433151B1 (de)
EP (1)	EP0974598B1 (de)
JP (1)	JP4573925B2 (de)
AT (1)	ATE521619T1 (de)
CY (1)	CY1112087T1 (de)
DK (1)	DK0974598T3 (de)
ES (1)	ES2372156T3 (de)
PT (1)	PT974598E (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE344269T1 (de) *	1998-12-10	2006-11-15	Pfizer Prod Inc	Carbamat und carbazat ketolid antibiotika
WO2006080954A1 (en) *	2004-07-28	2006-08-03	Ranbaxy Laboratories Limited	Ketolide derivatives as antibacterial agents
WO2006035301A2 (en) *	2004-09-27	2006-04-06	Ranbaxy Laboratories Limited	Erythromycin a derivatives as antibacterial agents
WO2006046112A2 (en) *	2004-10-25	2006-05-04	Ranbaxy Laboratories Limited	Ketolide derivatives as antibacterial agents
SI1836211T1 (sl) *	2004-12-21	2010-04-30	Pfizer Prod Inc	Makrolidi
WO2007054904A2 (en) *	2005-11-08	2007-05-18	Ranbaxy Laboratories Limited	Macrolides as anti-inflammatory agents
EP1960413A2 (de) *	2005-11-23	2008-08-27	Ranbaxy Laboratories Limited	Makrolidderivate als antibakterielle mittel
EP1954294A2 (de) *	2005-11-23	2008-08-13	Ranbaxy Laboratories Limited	Verwendung von makrolid-derivaten zur behandlung von akne
WO2007060518A2 (en) *	2005-11-23	2007-05-31	Ranbaxy Laboratories Limited	Ketolide derivatives as antibacterial agents
PL2102226T3 (pl) *	2006-12-12	2013-01-31	Zambon Spa	Związki makrolidowe o aktywności przeciwzapalnej
PE20211551A1 (es) *	2018-12-17	2021-08-16	Lunella Biotech Inc	Terapias de combinacion triple para fijar como objetivo mitocondrias y aniquilar celulas madre cancerosas

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3725385A (en) *	1970-11-02	1973-04-03	Abbott Lab	Process for the demethylation of 3-amino macrolides
IL99995A (en) *	1990-11-21	1997-11-20	Roussel Uclaf	Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) *	1992-11-05	1996-06-18	Roussel Uclaf	Erythromycin derivatives
FR2719587B1 (fr) *	1994-05-03	1996-07-12	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
PT876388E (pt) *	1995-11-08	2004-07-30	Abbott Lab	Derivados de eritromicina triciclica
FR2742757B1 (fr) *	1995-12-22	1998-01-30	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745290B1 (fr) *	1996-02-28	1998-04-03	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
DE69733439T2 (de)	1996-09-04	2006-05-04	Abbott Laboratories, Abbott Park	6-o-Substituierte Ketoliden mit antibakteriellen Wirkung
CA2303930A1 (en) *	1997-09-30	1999-04-08	Abbott Laboratories	3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity

1999
- 1999-07-07 JP JP19279099A patent/JP4573925B2/ja not_active Expired - Lifetime
- 1999-07-08 US US09/350,224 patent/US6433151B1/en not_active Expired - Lifetime
- 1999-07-08 ES ES99401706T patent/ES2372156T3/es not_active Expired - Lifetime
- 1999-07-08 DK DK99401706.9T patent/DK0974598T3/da active
- 1999-07-08 PT PT99401706T patent/PT974598E/pt unknown
- 1999-07-08 AT AT99401706T patent/ATE521619T1/de active
- 1999-07-08 EP EP99401706A patent/EP0974598B1/de not_active Expired - Lifetime
2011
- 2011-11-24 CY CY20111101154T patent/CY1112087T1/el unknown

Also Published As

Publication number	Publication date
EP0974598A2 (de)	2000-01-26
EP0974598B1 (de)	2011-08-24
PT974598E (pt)	2011-11-23
JP2000026494A (ja)	2000-01-25
DK0974598T3 (da)	2011-12-19
EP0974598A3 (de)	2003-12-17
JP4573925B2 (ja)	2010-11-04
CY1112087T1 (el)	2015-11-04
ES2372156T3 (es)	2012-01-16
US6433151B1 (en)	2002-08-13

Similar Documents

Publication	Publication Date	Title
CY1112087T1 (el)	2015-11-04	Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα
ATE129715T1 (de)	1995-11-15	O-methylderivate von azithromycin a, verfahren und zwischenverbindungen zu ihrer herstellung und deren verwendung zur herstellung von heilmitteln.
HUP9902576A1 (hu)	1999-12-28	Új eritromicinszármazékok, eljárás előállításukra és alkalmazásuk gyógyászati készítményekben
ATE124696T1 (de)	1995-07-15	Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung.
FR2518088B1 (fr)	1987-11-27	Nouveaux derives d'aminoacides, et leur application therapeutique
ATE129503T1 (de)	1995-11-15	Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien.
PT78304A (de)	1984-04-01	Neue n-phenyl-n'-cycloalkylalkanoyl-piperazine und verfahren zu deren herstellung
DE69527400D1 (de)	2002-08-22	Wasserlösliche camptothecin-derivate, verfahren zu deren herstellung und deren verwendung als antitumor-mittel
DE69620913D1 (de)	2002-05-29	Paraffinische solventzusammensetzungen hoher reinheit und verfahren zu deren herstellung
ATE145649T1 (de)	1996-12-15	Kardioaktive 17-aryl und 17-heterozyklyl-14 beta- 5alpha-androstane, androstene und androstadiene, ein verfahren zu ihrer herstellung und pharmazeutische präperate davon
FI101376B1 (fi)	1998-06-15	Menetelmä 3-bentsyyliamino-2-fenyylipiperidiinijohdannaisten valmistamiseksi
ATE215352T1 (de)	2002-04-15	Mittel und verfahren zur dauerhaften verformung von keratinfasern
ATE231160T1 (de)	2003-02-15	Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel
ATE19776T1 (de)	1986-05-15	Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
TR199700206A2 (xx)	1997-10-21	Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
NO981393L (no)	1998-05-25	Guanidinoproteasehemmere
DE59106966D1 (de)	1996-01-11	Verfahren zur Herstellung von 3-Amino-2-(het)aroyl-acrylsäurederivaten.
DE69112432D1 (de)	1995-09-28	Derivate von methylpiperazinoazepin, verfahren zu ihrer herstellung und verwendung.
ATE154346T1 (de)	1997-06-15	N-5-geschützte 2,5-diamino-4,6-dichlorpyrimidine und verfahren zu deren herstellung
ATE501158T1 (de)	2011-03-15	Neue 2-halogen-derivate von 5-o- desosaminylerythronolid a, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
DE3750396D1 (de)	1994-09-22	Optisch aktive 2,3-Dihydrobenzoxazinderivate und Verfahren zu deren Herstellung.
RU93033697A (ru)	1996-04-27	Производные 2-амино-n-[[[4-(аминокарбонил) пиримидин-2-ил]амино] алкил] пиримидин-4-карбоксамида, способ их получения и фармацевтическая композиция на их основе
ATE215561T1 (de)	2002-04-15	Methylsulfomycin 1, verfahren zu dessen herstellung und verwendung
ATE279434T1 (de)	2004-10-15	Neue (3,4,7,8,9,10) hexahydro-6, 10-dioxo-6h- pyridazino /1, 2-a/ /1, 2/ diazepin-1-carbonsäure-derivate, verfahren zu deren herstellung und deren verwendung zur herstellung pharmazeutischer wirkstoffe
DE3782457D1 (de)	1992-12-10	1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.

Legal Events

Date

Code

Title

Description

2012-04-15

UEP

Publication of translation of european patent specification

Ref document number: 0974598

Country of ref document: EP